A systematic review of epidemiological studies on neuropathic pain in the general population found that neuropathic pain is prevalent in the general population, with estimates ranging from 6.9% to 10%. The review included 21 studies, which varied in methods of data collection, case identification tools, and presentation of prevalence and incidence rates. These differences prevented a meta-analysis. The studies identified two main categories: chronic pain with neuropathic characteristics (3–17%) and neuropathic pain associated with specific conditions, such as postherpetic neuralgia (3.9–42.0/100,000 person-years), trigeminal neuralgia (12.6–28.9/100,000 person-years), and painful diabetic peripheral neuropathy (15.3–72.3/100,000 person-years). The review highlights the need for standardized approaches to identify neuropathic pain in future studies. The study also found that the prevalence of neuropathic pain in the general population is likely between 6.9% and 10%. The review emphasizes the importance of using validated screening tools to identify neuropathic pain and the need for future research to use standardized methods for accurate epidemiological data. The study also notes that the lack of a standardized definition and diagnostic criteria for neuropathic pain contributes to variability in prevalence and incidence estimates. The review concludes that future studies should use a standardized approach to identify neuropathic pain in the general population.A systematic review of epidemiological studies on neuropathic pain in the general population found that neuropathic pain is prevalent in the general population, with estimates ranging from 6.9% to 10%. The review included 21 studies, which varied in methods of data collection, case identification tools, and presentation of prevalence and incidence rates. These differences prevented a meta-analysis. The studies identified two main categories: chronic pain with neuropathic characteristics (3–17%) and neuropathic pain associated with specific conditions, such as postherpetic neuralgia (3.9–42.0/100,000 person-years), trigeminal neuralgia (12.6–28.9/100,000 person-years), and painful diabetic peripheral neuropathy (15.3–72.3/100,000 person-years). The review highlights the need for standardized approaches to identify neuropathic pain in future studies. The study also found that the prevalence of neuropathic pain in the general population is likely between 6.9% and 10%. The review emphasizes the importance of using validated screening tools to identify neuropathic pain and the need for future research to use standardized methods for accurate epidemiological data. The study also notes that the lack of a standardized definition and diagnostic criteria for neuropathic pain contributes to variability in prevalence and incidence estimates. The review concludes that future studies should use a standardized approach to identify neuropathic pain in the general population.